Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Glycopyrrolate Eflow® Closed System (CS) (nebulized Glycopyrrolate) in Pooled Data from Two Randomized, Double Blind, Placebo-Controlled Studies

Author(s):  
E.M. Kerwin ◽  
L. Murray ◽  
V. Ganapathy ◽  
C. Dembek ◽  
K. Rajagopalan
Sign in / Sign up

Export Citation Format

Share Document